SUVEN PHARMACEUTICALS LIMITED |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 659.7 INR | +1.99% |
|
+2.35% | -8.73% |
| Mar. 27 | Suven Pharmaceuticals Limited Announces Shifting of Registered Office | CI |
| Mar. 05 | Transcript : Cohance Lifesciences Limited, Suven Pharmaceuticals Limited - M&A Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Suven Pharmaceuticals Limited is an India-based company. The Company is engaged in the business of development and manufacturing of New Chemical Entity (NCE) based Intermediates, Active Pharmaceutical Ingredients (API), Specialty Chemicals and formulated drugs under contract research and manufacturing services for global pharmaceutical, biotechnology, and chemical companies. The Company operates through Pharmaceuticals Manufacturing and Services segment. Its geographical segments include India, the United States, Europe, and others. In India, the Company sells bulk drugs and intermediates, chemicals, and services. In the United States, the Company sells intermediates and services. In Europe, the Company sells bulk drugs and intermediates. In other countries, the Company sells bulk drugs, intermediates, and services. The Companyâs wholly owned subsidiary is Suven Pharma Inc.
Sector
Pharmaceuticals
Calendar
2024-06-19
- Q4 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
D-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
2
Last Close Price
659.7
INR
Average target price
685.5
INR
Spread / Average Target
+3.91%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -8.73% | 2.01B | |
| +25.83% | 661B | |
| +27.00% | 566B | |
| -6.76% | 352B | |
| +20.34% | 332B | |
| +3.00% | 283B | |
| +13.09% | 231B | |
| +5.46% | 200B | |
| -9.61% | 195B | |
| -6.26% | 145B |
- Stock Market
- Equities
- SUVENPHAR Stock
- News Suven Pharmaceuticals Limited
- US FDA Clears Suven Pharmaceuticals' API and Formulations Plants in Hyderabad, India
